Search research articles
Contact Us
Filters
Showing results (51-60 of 122) with videos related to
Page
of 13
Sort By:
Pharmacogenomics
|
May 26, 2018
Projected impact of a multigene pharmacogenetic test to optimize medication prescribing in cardiovascular patients
Olivia M Dong, Amy Li, Oscar Suzuki, et al.
Journal of the American College of Cardiology
|
August 2, 2005
Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis
Kirkwood F Adams, J Herbert Patterson, Wendy A Gattis, et al.
Pharmacotherapy
|
July 9, 2021
Effects of aging on clinical outcomes in patients receiving genotype-guided P2Y12 inhibitor selection after percutaneous coronary intervention
Brian Wood, Craig R Lee, Ian R Mulrenin, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
November 5, 2021
The Impact of Pregnancy on Antihypertensive Drug Metabolism and Pharmacokinetics: Current Status and Future Directions
Ian R Mulrenin, Julian E Garcia, Muluneh M Fashe, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
November 20, 2016
Implementation of inpatient models of pharmacogenetics programs
Larisa H Cavallari, Craig R Lee, Julio D Duarte, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 1, 2025
Impact of sex and pregnancy on hepatic CYP3A4 expression and activity in a humanized mouse model
Muluneh M Fashe, Taryn A Miner, Valeria Laboy Collazo, et al.
Frontiers in Pharmacology
|
December 6, 2021
Editorial: NSAIDs Pharmacogenomics
José A G Agúndez, Christine Formea, Andrea Gaedigk, et al.
Pharmacogenomics
|
April 29, 2020
Projected impact of pharmacogenomic testing on medications beyond antiplatelet therapy in percutaneous coronary intervention patients
Rachel M Black, Alexis K Williams, Lindsay Ratner, et al.
Hypertension (Dallas, Tex. : 1979)
|
November 25, 2010
Genetic variation in soluble epoxide hydrolase (EPHX2) is associated with forearm vasodilator responses in humans
Craig R Lee, Mias Pretorius, Robert N Schuck, et al.
Pharmacogenomics
|
October 3, 2024
Real-world evaluation of <i>CYP2C19</i> guided antiplatelet therapy in patients undergoing intracranial aneurysm repair
Layna P Fox, Kayla R Tunehag, Anh Nguyen, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 122) with videos related to
Sort By:
Page
of 13
Pharmacogenomics
|
May 26, 2018
Projected impact of a multigene pharmacogenetic test to optimize medication prescribing in cardiovascular patients
Olivia M Dong, Amy Li, Oscar Suzuki, et al.
Journal of the American College of Cardiology
|
August 2, 2005
Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis
Kirkwood F Adams, J Herbert Patterson, Wendy A Gattis, et al.
Pharmacotherapy
|
July 9, 2021
Effects of aging on clinical outcomes in patients receiving genotype-guided P2Y12 inhibitor selection after percutaneous coronary intervention
Brian Wood, Craig R Lee, Ian R Mulrenin, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
November 5, 2021
The Impact of Pregnancy on Antihypertensive Drug Metabolism and Pharmacokinetics: Current Status and Future Directions
Ian R Mulrenin, Julian E Garcia, Muluneh M Fashe, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
November 20, 2016
Implementation of inpatient models of pharmacogenetics programs
Larisa H Cavallari, Craig R Lee, Julio D Duarte, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 1, 2025
Impact of sex and pregnancy on hepatic CYP3A4 expression and activity in a humanized mouse model
Muluneh M Fashe, Taryn A Miner, Valeria Laboy Collazo, et al.
Frontiers in Pharmacology
|
December 6, 2021
Editorial: NSAIDs Pharmacogenomics
José A G Agúndez, Christine Formea, Andrea Gaedigk, et al.
Pharmacogenomics
|
April 29, 2020
Projected impact of pharmacogenomic testing on medications beyond antiplatelet therapy in percutaneous coronary intervention patients
Rachel M Black, Alexis K Williams, Lindsay Ratner, et al.
Hypertension (Dallas, Tex. : 1979)
|
November 25, 2010
Genetic variation in soluble epoxide hydrolase (EPHX2) is associated with forearm vasodilator responses in humans
Craig R Lee, Mias Pretorius, Robert N Schuck, et al.
Pharmacogenomics
|
October 3, 2024
Real-world evaluation of <i>CYP2C19</i> guided antiplatelet therapy in patients undergoing intracranial aneurysm repair
Layna P Fox, Kayla R Tunehag, Anh Nguyen, et al.
Page
of 13